Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Histologic Type

Explore clinical trials studying Neoplasms by Histologic Type. Study availability and eligibility vary by location and protocol.

30,134 public trials 6,478 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Histologic Type trial results

Recruiting

A Phase Ib/II Study to Evaluate Safety and Efficacy of Bexmarilimab in Combination With Doxorubicin in Metastatic Soft-tissue Sarcoma.

NCT07460986

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +2 more
Locations
  • Institut Català d' Oncologia Badalona (ICO) Badalona, Spain
  • Hospital de Cruces Barakaldo, Spain
  • Hospital Universitari Vall D'Hebron (VHIO) Barcelona, Spain
  • Hospital Clínico San Carlos Madrid, Spain
View Trial Details
Recruiting

Imatinib TDM in GIST

NCT05493215

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations
  • Markey Cancer Center Lexington, Kentucky, United States
View Trial Details
Recruiting

A Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia Patients

NCT07303660

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • State Budgetary Institution of Healthcare S.P. Botkin Moscow Multidisciplinary Scientific and Clinical Center of the Moscow Health Department Moscow, Russia
  • Medsi group Joint Stock Company Clinical Hospital Krasnogorsk, Moscow Oblast, Russia
  • State Regional Budgetary Healthcare Institution "Novgorod Regional Clinical Hospital" Veliky Novgorod, Novgorod Oblast, Russia
  • Federal State Budgetary Institution "Russian Research Institute of Hematology and Transfusiology of the Federal Medical and Biological Agency" Saint Petersburg, Sankt-Peterburg, Russia
View Trial Details
Recruiting

Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients

NCT05272826

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • NL Health Services St. John's, Newfoundland and Labrador, Canada
  • QEII Health Science Centre Halifax, Nova Scotia, Canada
  • London Health Sciences Centre London, Ontario, Canada
View Trial Details
Recruiting

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

NCT05536141

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site San Diego, California, United States
  • Research Site Santa Monica, California, United States
  • Research Site Miami, Florida, United States
View all 25 locations
View Trial Details
Recruiting

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

NCT05237986

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations
  • Children s Hospital of Los Angeles Los Angeles, California, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Seattle Children s Hospital Seattle, Washington, United States
View Trial Details

Related conditions